SCHEMBL22988913

SCHEMBL22988913

c1ccc(-c2nc(-c3ccc4cc(-n5c6ccc7cccc8oc9cccc%10ccc5c(c%109)c6c78)ccc4c3)nc(-c3cccc4c3c3ccccc3n4-c3ccccc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.32
ATM Q13315 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
ALDH1A1 P00352 3/20 0.31
MAPT P10636 2/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
TP53 P04637 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
KMT2A Q03164 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988905 0.91 TERT (0.33) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL22989253 0.89 KDM4E (0.31) KDM4EATML3MBTL1
SCHEMBL22988904 0.88 MEN1 (0.39) KDM4EL3MBTL1ALDH1A1MAPTTP53
SCHEMBL22988910 0.87 ALDH1A1 (0.41) KDM4EALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL24361785 0.86 MAPT (0.33) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL22988911 0.86 S1PR5 (0.33)
SCHEMBL24363571 0.86 ALDH1A1 (0.33) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL23569678 0.85 KDM4E (0.34) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL22988907 0.85 S1PR1 (0.32) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL24361968 0.85 ALDH1A1 (0.35) KDM4EATML3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 KDM4E 568/4885ATM 1893/4885L3MBTL1 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.